SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager – Informatics.
In the episode titled "The Power of Informatics in Clinical Decision-Making," Wierschem shares how informatics platforms are transforming laboratory operations by connecting instruments, data systems and clinical decisions. Drawing on over 30 years of laboratory experience, he explains how informatics has evolved from a helpful tool to a critical engine driving lab efficiency, data integrity and patient care.
Key insights include:
This episode underscores how informatics is helping labs stay agile, secure and future-ready – especially as demands for speed and accuracy continue to grow.
The QuidelOrtho Science Bytes podcast is available on major streaming platforms and at: https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to lab, clinic to hospital. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.


| Last Trade: | US$28.95 |
| Daily Change: | 0.63 2.22 |
| Daily Volume: | 989,977 |
| Market Cap: | US$1.970B |
November 05, 2025 November 03, 2025 September 22, 2025 August 19, 2025 | |

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load